DIVYA SHAH: Open Payments
NPI 1316343643 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 11 payments from 7 companies in 2025. Trend: 2023 $1,206 · 2024 $827 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Alkermes, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Corium, LLC | 1 | $12 |
Products named: CAPLYTA, VRAYLAR, VIVITROL, REXULTI, ARISTADA, TRINTELLIX, SPRAVATO, Azstarys.
Industry payments across GA — which companies pay providers there.
